About eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
